Taken together, our results suggest that QIL1 and other MICOS subunits represent potential candidates for mutations in patients with unexplained early onset neurological deterioration with optic and cerebellar atrophy progressing over time combined with liver disease and 3-methylglutaconic aciduria. The gene discussed is MICOS13; the disease is Cerebellar atrophy.